FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...